Dynamic Technology Lab’s Ionis Pharmaceuticals IONS Stock Holding History

Dynamic Technology Lab’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,273	Closed	-$267K	–	1233
2023 Q4	$267K	Buy	+5,273	New	+$253K	0.03%	790
2023 Q1	–	Sell	-25,580	Closed	-$966K	–	1300
2022 Q4	$966K	Buy	+25,580	New	+$1.08M	0.1%	348
2022 Q3	–	Sell	-18,310	Closed	-$678K	–	1320
2022 Q2	$678K	Buy	+18,310	New	+$690K	0.08%	453
2022 Q1	–	Sell	-11,134	Closed	-$339K	–	1283
2021 Q4	$339K	Sell	11,134 -366	-3%	-$11.5K	0.04%	753
2021 Q3	$386K	Buy	+11,500	New	+$433K	0.05%	639
2020 Q4	–	Sell	-5,174	Closed	-$246K	–	1152
2020 Q3	$246K	Buy	+5,174	New	+$287K	0.04%	738
2018 Q2	–	Sell	-11,190	Closed	-$493K	–	1149
2018 Q1	$493K	Buy	11,190 +5,650	+102%	+$287K	0.07%	493
2017 Q4	$278K	Sell	5,540 -60	-1%	-$3.29K	0.05%	730
2017 Q3	$285K	Sell	5,600 -1,900	-25%	-$99.5K	0.05%	757
2017 Q2	$381K	Buy	+7,500	New	+$349K	0.07%	557
2015 Q3	–	Sell	-3,800	Closed	-$219K	–	913
2015 Q2	$219K	Buy	+3,800	New	+$242K	0.08%	584

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dynamic Technology Lab's IONS Position: Q1 2024 in Review

Dynamic Technology Lab sold out of Ionis Pharmaceuticals (IONS) in Q1 2024, closing a stake of 5,273 shares — an estimated $267K sold.

Dynamic Technology Lab first reported a position in IONS in Q2 2015 and held it in 11 quarters. The position peaked at $966K in Q4 2022. 361 funds tracked by Wall St. Rank hold IONS as of Q1 2024.

Dynamic Technology Lab reported no remaining Ionis Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Dynamic Technology Lab sold 5,273 Ionis Pharmaceuticals shares in Q1 2024, an estimated $267K.
Dynamic Technology Lab first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 11 quarters.
Dynamic Technology Lab's Ionis Pharmaceuticals position peaked at $966K in Q4 2022.
361 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.